- Last edited on February 1, 2024
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Previous revision | ||
teaching:pharmaceutical-industry-influence [on June 19, 2020] |
teaching:pharmaceutical-industry-influence [on June 19, 2020] |
||
---|---|---|---|
Line 55: | Line 55: | ||
===== Reform ===== | ===== Reform ===== | ||
- | <callout>“t is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." | + | <callout>“It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." |
\\ \\ | \\ \\ | ||
-- //Dr. Marcia Angell, Drug Companies & Doctors: A Story of Corruption//</callout> | -- //Dr. Marcia Angell, Drug Companies & Doctors: A Story of Corruption//</callout> |